Ryali Sriram has filed 9 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 55000 shares of Caribou Biosciences, Inc. ($CRBU) on February 20, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Caribou Biosciences, Inc. | $CRBU | Ryali Sriram | Chief Financial Officer | A | Common Stock | 55000 | $0.00 | 72,360.0000 | 93,468,038 | 316.82% | 0.06% |
| Feb. 20, 2026 | Caribou Biosciences, Inc. | $CRBU | Ryali Sriram | Chief Financial Officer | A | Option to purchase Common Stock | 247500 | $0.00 | 247,500.0000 | 93,468,038 | 9999.99% | 0.26% |
| Jan. 29, 2025 | Caribou Biosciences, Inc. | $CRBU | Ryali Sriram | Chief Financial Officer | P | Common Stock | 17360 | $1.42 | 17,360.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2025 | Caribou Biosciences, Inc. | $CRBU | Ryali Sriram | Chief Financial Officer | A | Option to purchase Common Stock | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | CODEXIS, INC. | $CDXS | Ryali Sriram | Chief Financial Officer | A | Stock Option (Right to Buy) | 314125 | $0.00 | 314,125.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | CODEXIS, INC. | $CDXS | Ryali Sriram | Chief Financial Officer | A | Common Stock | 52350 | $0.00 | 175,791.0000 | 0 | 42.41% | 0.00% |
| Sept. 8, 2023 | CODEXIS, INC. | $CDXS | Ryali Sriram | Chief Financial Officer | P | Common Stock | 11650 | $1.70 | 123,441.0000 | 0 | 10.42% | 0.00% |
| Feb. 10, 2023 | CODEXIS, INC. | $CDXS | Ryali Sriram | Chief Financial Officer | A | Common Stock | 111791 | $0.00 | 111,791.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2023 | CODEXIS, INC. | $CDXS | Ryali Sriram | Chief Financial Officer | A | Stock Option (Right to Buy) | 372637 | $0.00 | 372,637.0000 | 0 | 9999.99% | 0.00% |